If this was forwarded to you, subscribe here - I send two of these a week.

---

Per Healthcare Dealflow's March 2026 recap, March closed at 297 deals. 70-plus in Physician Services. PE had a hand in 70% of those.

That's the closed count. The auction count matters more.

In March alone: Webster brought Bristol Hospice to market on about $140M of EBITDA. Ares started prep on Lockwood Group at $70M. Arlington hired an advisor on Everest Clinical Research at $45M. Varsity lined up Ventra Health with Moelis. Grant Avenue put Ovation Healthcare with Baird. InTandem began fireside chats on Pediatric Home Service at McDermott

Seven named processes loading into Q2. Every one creates a second-order effect most origination teams aren't pricing in yet.

What an Auction Does to the Practice Next Door

When a PE-backed platform in a specialty goes to auction, the independent practices around it recalibrate.

A founder planning to hold three more years has to decide whether to ride out the transition or move ahead of it. A junior partner waiting on a retirement payout starts asking different questions about timing. A local competitor who was never going to sell sees a new platform owner entering their market and reconsiders their posture.

That shift plays out off the record. In the founder's calendar. In the junior partner's draft folder. In the competitor's website updates. Weeks or months before any filter surfaces the practice as a prospect worth calling.

Research on B2B purchasing behavior points to external trigger events as among the strongest predictors of decision timing. Something happens in the environment, and decisions that were "someday" become "this quarter." For physician practice owners, a PE-backed adjacent platform going to auction is one of the sharpest triggers in the market.

Based on what I've seen across origination workflows this year, most teams are still anchored to the filter. The auction announcement lands in the inbox. Someone reads it, maybe adds the acquirer to a tracking list, and that's where it stops. The shadow universe of 20 to 40 practices newly eligible for a conversation gets missed. The teams are doing the work. The tools don't surface context at that level, and no one has a system to build one in the time the trigger window is open.

Why Most Teams Don't Catch the Shadow Universe

Three patterns repeat across the origination teams I've talked to this year.

The filter runs on what's already been categorized. The shadow universe is defined by context - who sits adjacent to this specific auction, in this specific MSA, in this specific specialty, with this specific payer mix. Commercial databases don't index context at that level because they aren't built to.

The trigger window is short. When an auction is announced, the window to reach adjacent practices while they are newly receptive runs maybe 60 to 90 days before the next round of market chatter moves them back into "someday." No origination team has 60 spare hours to build a shadow map inside that window.

The MD champions who would approve the spend on building this capability often don't realize the shadow universe exists. The auction is the visible event. The 20 to 40 practices reconsidering their posture are invisible by design.

How I Think About Building a Shadow Map

I'm not going to walk through the specific methodology here. That's the work product.

What I will say is that the shadow universe for any named auction breaks into five recognizable categories - direct geographic competitors, adjacent-MSA independents, sub-specialty peers, referring networks, and recently departed partners. Each category carries its own public data signature and its own trigger profile. Triangulating across them against the right public sources produces a ranked list of 8 to 12 practices worth a first touch within six business days of the auction announcement.

Most teams doing this ad hoc take three to four weeks. By the time the list is ready, the trigger window has closed and the adjacent practices have moved back into their pre-auction posture.

The Question for Q2

If you're watching any of those seven March processes right now - or any of the processes that will hit in April, May, or June - here's the question worth asking this week: who on your team owns the shadow map for the adjacent universe, and how fast can they build it?

The practices that will transact in Q3 and Q4 aren't the ones showing up in your filter today. They're the ones sitting in a specialty where a platform just went to market, making a decision they didn't expect to be making yet.

If you're staring at a named process and want to talk about the adjacent universe, reply with the auction and the market. I'll tell you what I can see from public data that your feed isn't showing you.

-Shawn

---

On Thursday: why 42% of qualified origination targets end in no decision, and the research finding most deal leaders are reading the wrong way.

---

What's one Q2 auction you're tracking right now? Hit reply - I read every one.

---

This newsletter is for informational purposes only and does not constitute investment, legal, or financial advice.

 

Reply

Avatar

or to participate

Keep Reading